MedTrace Logo

Haskap and Endurance Running Performance

NCT04837898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-04-13

No results posted yet for this study

Summary

This study will employ a randomised, double-blind, placebo-controlled, independent groups experimental design. Submaximal, maximal and 5 km time trial running performance will be assessed before and after supplementation with haskap berry or a placebo.

Conditions

  • Exercise Performance

Interventions

DIETARY_SUPPLEMENT

Haskapa

Haskapa Ltd, Oxford, UK

DIETARY_SUPPLEMENT

Placebo

isocaloric to the haskap powder

Sponsors & Collaborators

  • Mibelle Group Biochemistry

    collaborator INDUSTRY

  • Haskapa Ltd

    collaborator UNKNOWN

  • Northumbria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2021-11-08
Completion
2021-12-08

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04837898 on ClinicalTrials.gov